pmc logo image
Logo of gutGutCurrent TOCInstructions to authors
Journal List > Gut > v.49(3); Sep 2001

Formats:
Gut. 2001 September; 49(3): 431–435.
doi: 10.1136/gut.49.3.431.
PMCID: PMC1728437
Copyright notice
Outcome of liver disease in children with Alagille syndrome: a study of 163 patients
P Lykavieris, M Hadchouel, C Chardot, and O Bernard
Service d'Hépatologie Pédiatrique, Hôpital de Bicêtre, 94275 Le Kremlin Bicêtre Cedex, France.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
BACKGROUND AND AIMS—Various opinions have been expressed as to the long term prognosis of liver disease associated with Alagille syndrome (AGS).
PATIENTS AND METHODS—We reviewed the outcome of 163 children with AGS and liver involvement, investigated from 1960 to 2000, the end point of the study (median age 10 years (range 2 months to 44 years)) being death, liver transplantation, or the last visit.
RESULTS—At the study end point, of the 132 patients who presented with neonatal cholestatic jaundice, 102 remained jaundiced, 112 had poorly controlled pruritus, and 40 had xanthomas; cirrhosis was found in 35/76 livers, varices in 25/71 patients, and liver transplantation had been carried out in 44 patients (33%). Forty eight patients died, 17 related to complications of liver disease. Of 31 patients who did not present with neonatal cholestatic jaundice, five were jaundiced at the study end point, 17 had well controlled pruritus, and none had xanthomas; cirrhosis was found in 6/18 patients, varices in 4/11, and none underwent liver transplantation. Nine patients died, two of liver disease. In the whole series, actuarial survival rates with native liver were 51% and 38% at 10 and 20 years, respectively, and overall survival rates were 68% and 62%, respectively. Neonatal cholestatic jaundice was associated with poorer survival with native liver (p=0.0004).
CONCLUSIONS—The prognosis of liver disease in AGS is worse in children who present with neonatal cholestatic jaundice. However, severe liver complications are possible even after late onset of liver disease, demanding follow up throughout life.


Keywords: Alagille syndrome; cholestasis; end stage liver disease; liver transplantation
Full Text
The Full Text of this article is available as a PDF (124K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Alagille D, Odièvre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr. 1975 Jan;86(1):63–71. [PubMed]
  • Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, Costa T, Pierpont ME, Rand EB, Piccoli DA, Hood L, Spinner NB. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997 Jul;16(3):243–251. [PubMed]
  • Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, Meltzer PS, Spinner NB, Collins FS, Chandrasekharappa SC. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997 Jul;16(3):235–242. [PubMed]
  • Riely CA, Cotlier E, Jensen PS, Klatskin G. Arteriohepatic dysplasia: a benign syndrome of intrahepatic cholestasis with multiple organ involvement. Ann Intern Med. 1979 Oct;91(4):520–527. [PubMed]
  • Alagille D, Estrada A, Hadchouel M, Gautier M, Odièvre M, Dommergues JP. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr. 1987 Feb;110(2):195–200. [PubMed]
  • Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome. J Med Genet. 1997 Feb;34(2):152–157. [PubMed]
  • Tzakis AG, Reyes J, Tepetes K, Tzoracoleftherakis V, Todo S, Starzl TE. Liver transplantation for Alagille's syndrome. Arch Surg. 1993 Mar;128(3):337–339. [PubMed]
  • Schwarzenberg SJ, Grothe RM, Sharp HL, Snover DC, Freese D. Long-term complications of arteriohepatic dysplasia. Am J Med. 1992 Aug;93(2):171–176. [PubMed]
  • Cardona J, Houssin D, Gauthier F, Devictor D, Losay J, Hadchouel M, Bernard O. Liver transplantation in children with Alagille syndrome--a study of twelve cases. Transplantation. 1995 Aug 27;60(4):339–342. [PubMed]
  • Hoffenberg EJ, Narkewicz MR, Sondheimer JM, Smith DJ, Silverman A, Sokol RJ. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr. 1995 Aug;127(2):220–224. [PubMed]
  • Quiros-Tejeira RE, Ament ME, Heyman MB, Martin MG, Rosenthal P, Hall TR, McDiarmid SV, Vargas JH. Variable morbidity in alagille syndrome: a review of 43 cases. J Pediatr Gastroenterol Nutr. 1999 Oct;29(4):431–437. [PubMed]
  • Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999 Mar;29(3):822–829. [PubMed]
  • Kaufman SS, Wood RP, Shaw BW, Jr, Markin RS, Gridelli B, Vanderhoof JA. Hepatocarcinoma in a child with the Alagille syndrome. Am J Dis Child. 1987 Jun;141(6):698–700. [PubMed]
  • Békássy AN, Garwicz S, Wiebe T, Hägerstrand I, Jensen OA. Hepatocellular carcinoma associated with arteriohepatic dysplasia in a 4-year-old girl. Med Pediatr Oncol. 1992;20(1):78–83. [PubMed]
  • Deprettere A, Portmann B, Mowat AP. Syndromic paucity of the intrahepatic bile ducts: diagnostic difficulty; severe morbidity throughout early childhood. J Pediatr Gastroenterol Nutr. 1987 Nov–Dec;6(6):865–871. [PubMed]
  • Adams PC. Hepatocellular carcinoma associated with arteriohepatic dysplasia. Dig Dis Sci. 1986 Apr;31(4):438–442. [PubMed]
  • MacMillan JC, Shepherd R, Heritage M. Arteriohepatic dysplasia (Alagille syndrome; Watson-Alagille syndrome). Baillieres Clin Gastroenterol. 1998 Jun;12(2):275–291. [PubMed]
Figures and Tables
Figure 1
Figure 1
Figure 1  
Survival with native liver in 163 patients with Alagille syndrome and chronic liver disease. 1, 132 patients with neonatal cholestatic jaundice; 2, 31 patients with late onset cholestasis (p=0.0004).
Articles from Gut are provided here courtesy of
BMJ Group

Links